Headlines about MedEquities Realty Trust (NYSE:MRT) have been trending positive on Tuesday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MedEquities Realty Trust earned a coverage optimism score of 0.25 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 46.0953634619543 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

MedEquities Realty Trust (MRT) opened at $10.98 on Tuesday. MedEquities Realty Trust has a 52 week low of $10.06 and a 52 week high of $13.06. The stock has a market capitalization of $348.68, a PE ratio of 27.45 and a beta of -0.74.

MedEquities Realty Trust (NYSE:MRT) last posted its earnings results on Tuesday, November 7th. The financial services provider reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.30 by ($0.13). MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%. The company had revenue of $15.77 million during the quarter, compared to analysts’ expectations of $15.49 million. analysts expect that MedEquities Realty Trust will post 1.12 earnings per share for the current fiscal year.

MRT has been the topic of several research reports. KeyCorp set a $13.00 price target on MedEquities Realty Trust and gave the company a “buy” rating in a research note on Sunday, October 29th. B. Riley restated a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Capital One Financial initiated coverage on MedEquities Realty Trust in a research note on Monday, October 23rd. They set an “equal weight” rating and a $13.00 price target on the stock. Zacks Investment Research upgraded MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price target on the stock in a research note on Wednesday, November 15th. Finally, ValuEngine upgraded MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. MedEquities Realty Trust currently has an average rating of “Buy” and an average price target of $13.00.

In related news, Director Randy L. Churchey bought 5,300 shares of the business’s stock in a transaction on Monday, November 20th. The shares were bought at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the completion of the purchase, the director now directly owns 46,776 shares of the company’s stock, valued at $508,455.12. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO John W. Mcroberts bought 18,000 shares of the business’s stock in a transaction on Friday, November 17th. The stock was bought at an average price of $10.74 per share, for a total transaction of $193,320.00. The disclosure for this purchase can be found here. Insiders acquired 23,600 shares of company stock worth $254,129 in the last quarter. 2.50% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “MedEquities Realty Trust (MRT) Earns News Impact Rating of 0.25” was reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.watchlistnews.com/medequities-realty-trust-mrt-earns-news-impact-rating-of-0-25/1819546.html.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.